Preclinical evaluation of 4-methylthiobutyl isothiocyanate on liver cancer and cancer stem cells with different p53 status.
Lamy E, Hertrampf A, Herz C, Schüler J, Erlacher M, Bertele D, Bakare A, Wagner M, Weiland T, Lauer U, Drognitz O, Huber R, Rohn S, Giesemann T, Mersch-Sundermann V.
Lamy E, et al.
PLoS One. 2013 Aug 2;8(8):e70846. doi: 10.1371/journal.pone.0070846. Print 2013.
PLoS One. 2013.
PMID: 23936472
Free PMC article.